From Diagnosis to Treatment: Building a HCV Toolkit - CME

Add to Calendar From Diagnosis to Treatment: Building a HCV Toolkit - CME 2/27/2020 12:00:00 PM 2/27/2020 4:30:00 PM America/Mexico_City Other false MM/DD/YYYY


Thursday, February 27, 2020, 12:00 PM - 4:30 PM, Other, LaFollette, TN


MedicinePathology, Microbiology and ImmunologyPharmacologyNursing

AMA PRA Category 1 Credits™ (3.50 hours), Non-Physician Attendance (3.50 hours)


This half-day training program is designed for clinical providers who are new to HCV treatment. It's best suited for physicians, physician assistants, nurse practitioners, pharmacists, and nurses. It may not be suitable for non-clinical staff.



Objectives
At the conclusion of this activity, participants should be able to:

  1. Identify risk factors for HCV which indicate that a patient should be tested
  2. Discuss the epidemiology of HCV and current trends
  3. Describe the pretreatment evaluation, including patient history, physical exam, lab assessments, staging, and readiness assessment
  4. Classify the different HCV genotypes and recommended treatment selections
  5. Discuss appropriate monitoring while a patient is undergoing HCV treatment
  6. Identify common drug-drug interactions and pharmacological considerations
  7. Summarize perinatal transmission and pediatric HCV


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this live activity for a maximum 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.